This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Mark Neil Tolentino, PhD
Senior Scientist at Alnlyam Pharmaceuticals Inc.
Speaker

Profile

Dr. Mark Tolentino obtained his bachelors degree in Chemistry from University of Philippines in 2014. He received his PhD in Chemistry from the University of Connecticut in 2021 under the mentorship of Prof. Jessica L. Rouge. His graduate work focused on the development of stimuli-responsive nanoparticles by combining soft and inorganic materials for oligonucleotide and protein delivery applications. His current role at Alnylam involves developing new bio conjugation reactions for delivery of synthetic oligonucleotides for extra-hepatic delivery.

Agenda Sessions

  • Delivering RNAi to Extra-hepatic Tissues

    11:15am